Long Corridor Asset Management LTD Bei Gene, Ltd. Transaction History
Long Corridor Asset Management LTD
- $68.7 Million
- Q1 2024
A detailed history of Long Corridor Asset Management LTD transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Long Corridor Asset Management LTD holds 10,046 shares of BGNE stock, worth $1.62 Million. This represents 2.29% of its overall portfolio holdings.
Number of Shares
10,046Holding current value
$1.62 Million% of portfolio
2.29%Shares
8 transactions
Others Institutions Holding BGNE
# of Institutions
213Shares Held
45.1MCall Options Held
76.5KPut Options Held
72.3K-
Baker Bros. Advisors LP New York, NY10.6MShares$1.7 Billion20.93% of portfolio
-
Capital International Investors Los Angeles, CA7.06MShares$1.14 Billion0.23% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$833 Million17.98% of portfolio
-
Primecap Management CO Pasadena, CA5MShares$805 Million0.59% of portfolio
-
Baillie Gifford & CO3.68MShares$593 Million0.42% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $16.7B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...